Molecular predictive factors of outcome of radiotherapy in cervical cancer

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F11%3A10106307" target="_blank" >RIV/00216208:11150/11:10106307 - isvavai.cz</a>
Alternative codes found
RIV/00179906:_____/11:10106307
Result on the web
<a href="http://dx.doi.org/10.4149/neo_2011_06_469" target="_blank" >http://dx.doi.org/10.4149/neo_2011_06_469</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.4149/neo_2011_06_469" target="_blank" >10.4149/neo_2011_06_469</a>

Result language
angličtina
Original language name
Molecular predictive factors of outcome of radiotherapy in cervical cancer
Original language description
Radical radiotherapy with concurrent cisplatin-based chemotherapy is an established treatment for cervical cancer patients with stage FIGO IIB and higher. The tumor control can be achieved in 40-80% of patients, the treatment is associated with the riskof late postiradiation complications in 10-15% of cases. Detection of the factors predictive for tumor control and late morbidity is a possible direction how to individualize radiotherapy dose and technique. The aim of our review is to summarize resultsof studies inquiring various molecular markers predicting tumor response to radiotherapy and a risk of late complications.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—

Project
<a href="/en/project/NT11334" target="_blank" >NT11334: Genetic prediction of late toxicity of radiotherapy for cervical cancer</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2011
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)